+924.9%
MRNA vs NBIX
+8.2%
+916.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NBIX | Excess | Alpha |
|---|---|---|---|---|
| 1D | -6.5% | -3.8% | -2.8% | -3.7% |
| 7D | +8.4% | +9.1% | -0.7% | +1.4% |
| 30D | +28.8% | +9.8% | +19.0% | +19.5% |
| 3M | +329.2% | -1.1% | +330.3% | +334.9% |
| 6M | +416.9% | +18.3% | +398.6% | +364.2% |
| YTD | +718.8% | +12.6% | +706.1% | +646.7% |
| 1Y | +924.9% | +3.9% | +921.0% | +862.0% |
| All | +924.9% | +8.2% | +916.7% | +862.0% |
Cumulative growth
Daily Returns
Daily percentage return beside NBIX.
Daily Out/Under-Performance
Portfolio return minus NBIX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NBIX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NBIX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling